Abstract
The ability of antibody to co-operate with certain non-immune lymphoid cells in the rejection of tumours has been studied both in vitro and in vivo. Anti-serum raised in rabbits against a PVGc rat leukosis can be rendered “tumour specific” by in vivo absorption in normal PVGc rats and this antiserum can be shown to have lymphocyte dependent antibody (LDA) activity against the tumour cell in vitro. Complement lytic activity of the antiserum is weak or absent against the tumour. Passive administration of the antiserum to rats protects the animals against the development of leukaemia. Maximum protection occurs if the anti-serum is given before the tumour inoculum and is less effective given after the tumour inoculum. No protective effect can be demonstrated with “tumour specific” allo-antisera or syngeneic antisera against the tumour and no in vitro LDA activity can be detected against the tumour in vitro. Good correlation exists between LDA activity in the sera of the recipients and the in vivo protective effect.
The results are discussed in terms of the kinetics of cell killing after models described for killing by chemotherapeutic agents in animals.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- GORER P. A., AMOS D. B. Passive immunity in mice against C57BL leukosis E.L. 4 by means of iso-immune serum. Cancer Res. 1956 May;16(4):338–343. [PubMed] [Google Scholar]
- Hersey P., Cullen P., MacLennan I. C. Lymphocyte-dependent cytotoxic antibody activity against human transplantation antigens. Transplantation. 1973 Jul;16(1):9–16. doi: 10.1097/00007890-197307000-00003. [DOI] [PubMed] [Google Scholar]
- Hersey P., MacLennan I. C., Campbell A. C., Harris R., Freeman C. B. Cytotoxicity against human leukaemic cells. I. Demonstration of antibody-dependent lymphocyte killing of human allogeneic myeloblasts. Clin Exp Immunol. 1973 Jun;14(2):159–167. [PMC free article] [PubMed] [Google Scholar]
- Lamon E. W., Skurzak H. M., Klein E., Wigzell H. In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen. J Exp Med. 1972 Nov 1;136(5):1072–1079. doi: 10.1084/jem.136.5.1072. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MacLennan I. C. Antibody in the induction and inhibition of lymphocyte cytotoxicity. Transplant Rev. 1972;13:67–90. doi: 10.1111/j.1600-065x.1972.tb00060.x. [DOI] [PubMed] [Google Scholar]
- Old L. J., Stockert E., Boyse E. A., Geering G. A study of passive immunization against a transplanted G+ leukemia with specific antiserum. Proc Soc Exp Biol Med. 1967 Jan;124(1):63–68. doi: 10.3181/00379727-124-31667. [DOI] [PubMed] [Google Scholar]
- Perlmann P., Perlmann H., Wigzell H. Lymphocyte mediated cytotoxicity in vitro. Induction and inhibition by humoral antibody and nature of effector cells. Transplant Rev. 1972;13:91–114. doi: 10.1111/j.1600-065x.1972.tb00061.x. [DOI] [PubMed] [Google Scholar]
- Pollack S. Specific "arming" of normal lymph-node cells by sera from tumor-bearing mice. Int J Cancer. 1973 Jan 15;11(1):138–142. doi: 10.1002/ijc.2910110116. [DOI] [PubMed] [Google Scholar]
- Skipper H. E., Schabel F. M., Jr, Wilcox W. S. Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells. Cancer Chemother Rep. 1967 Jun;51(3):125–165. [PubMed] [Google Scholar]
- Skurzak H. M., Klein E., Yoshida T. O., Lamon E. W. Synergistic or antgonistic effect of different antibody concentrations on in vitro lymphocyte cytotoxicity in the Moloney sarcoma virus system. J Exp Med. 1972 Apr 1;135(4):997–1002. doi: 10.1084/jem.135.4.997. [DOI] [PMC free article] [PubMed] [Google Scholar]